Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk A/S today announced 2024 earnings ... If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare ...

A Verlingue Portugal tem o prazer de informar sobre a nomeação de Catarina Lança para o cargo de Head of Life & Personal ...

Share Buyback Program: DKK20 billion concluded. Novo Nordisk AS (NYSE:NVO) reported a strong 26% sales growth and 26% operating profit growth for 2024. The company expanded its patient reach ...

Capitão América 4: Sam Wilson vai receber o soro do super soldado em Admirável Mundo Novo? Em Capitão América 4, Sam Wilson, agora com o manto que anteriormente pertenceu a Steve Rogers ...

Depois que uma atualização da Valve mencionava as GPUs RDNA 4, muitos pensavam que a empresa estava trabalhando em um Steam Deck 2 ou mesmo em um novo Steam Machine, ou seja, um console de mesa.

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

Dividend Increase: 21% increase to DKK11.40 per share. Share Buyback Program: DKK20 billion concluded. Novo Nordisk AS (NYSE:NVO) reported a strong 26% sales growth and 26% operating profit growth for ...

Capitão América: Admirável Mundo Novo chega aos cinemas brasileiros no ... Seu personagem em Capitão América 4 não estava planejado originalmente, mas foi incluído nas refilmagens que ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...